Trial Information
Inclusion Criteria:
- You must have been diagnosed with bladder cancer that has recurred or moved to a
new part of the body.
- You must have at least one tumor that can be physically measured or scanned by x-ray.
- You may not have had previous chemotherapy (drug) treatment OR you have had surgery
followed by one chemotherapy treatment at least 4 months ago.
Exclusion Criteria:
- You may not have used an experimental medicine or device within the past month.
- Cancer that has spread to your brain.
- If you are unwilling or unable to take folic acid or vitamin B12 supplements.
Type of Study:
Interventional
Study Design:
Primary Purpose: Treatment
Authority:
United States: Food and Drug Administration
Study ID:
4699
NCT ID:
NCT00034593
Start Date:
Completion Date:
Related Keywords:
- Urologic Neoplasms
- Bladder cancer
- metastatic
- transitional cell carcinoma of the urothelium
- Neoplasms
- Carcinoma, Transitional Cell
- Urologic Neoplasms